Santen Pharmaceutical Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 283,000 | 0.0778% |
Public Companies | 6,204,000 | 1.7% |
State or Government | 7,607,000 | 2.09% |
General Public | 153,699,193 | 42.2% |
Institutions | 196,148,361 | 53.9% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
22,912,400 | US$229.1m | 0% | 0.08% | |||
20,839,347 | US$208.4m | 0% | 2.52% | |||
18,290,500 | US$182.9m | 33.7% | 0.7% | |||
14,639,486 | US$146.4m | -21.9% | 0.03% | |||
11,338,800 | US$113.4m | 0% | 0.07% | |||
10,969,169 | US$109.7m | -7.19% | no data | |||
10,662,000 | US$106.6m | 0% | 0.11% | |||
10,134,100 | US$101.3m | -33.9% | 0.09% | |||
9,041,567 | US$90.4m | 15.4% | 0.01% | |||
8,202,700 | US$82.0m | 0% | 0.03% | |||
7,607,000 | US$76.1m | 0% | no data | |||
6,988,717 | US$69.9m | -25% | 0.25% | |||
6,863,000 | US$68.6m | 0% | no data | |||
6,220,058 | US$62.2m | -1.2% | no data | |||
6,204,000 | US$62.0m | 0% | no data | |||
4,961,500 | US$49.6m | -2.45% | 0.04% | |||
3,649,671 | US$36.5m | -21.8% | 0.01% | |||
2,263,700 | US$22.6m | -7.59% | 0.02% | |||
1,821,200 | US$18.2m | 13.3% | 0.02% | |||
1,820,939 | US$18.2m | 20.1% | no data | |||
1,622,500 | US$16.2m | 0% | 0.16% | |||
1,564,600 | US$15.6m | 0% | 0.28% | |||
1,384,937 | US$13.8m | 0% | 0.01% | |||
1,370,453 | US$13.7m | 32.3% | no data | |||
1,070,000 | US$10.7m | 0% | 0.01% |